• Cho Yong Joon's group raised its DongKoo Bio & Pharma holding to 37.2% from 37.18% as of Nov. 6, 2026.
• The increase reflected Cho's purchase of 6,746 shares through market transactions on Oct. 29 and Nov. 4.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DongKoo Bio & Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261109000222), on November 09, 2026, and is solely responsible for the information contained therein.